Quarterly report pursuant to Section 13 or 15(d)

Segment reporting (Tables)

v3.8.0.1
Segment reporting (Tables)
6 Months Ended
Jan. 31, 2018
Segment Reporting [Abstract]  
Schedule of Segment Reporting Information, by Segment [Table Text Block] The following financial information represents the operating results of the reportable segments of the Company:

Three months ended January 31, 2018

  Clinical
Labs
    Life
Sciences
    Therapeutics     Other     Consolidated  
Revenues:                                        
Clinical laboratory services   $ 19,530                       $ 19,530  
Product revenues         $ 7,122                   7,122  
Royalty and license fee income           300                   300  
      19,530       7,422                   26,952  
Operating costs and expenses:                                        
Cost of clinical laboratory services     11,730                         11,730  
Cost of product revenues           3,877                   3,877  
Research and development           591     $ 221             812  
Selling, general and administrative     6,107       2,899           $ 2,064       11,070  
Provision for uncollectible accounts receivable     800       (21 )                 779  
Legal fee expense     8       25             1,667       1,700  
Total operating costs and expenses     18,645       7,371       221       3,731       29,968  
                                         
Operating income (loss)     885       51       (221 )     (3,731 )     (3,016 )
                                         
Other income (expense):                                        
Interest     (23 )     11             197       185  
Other     3       1             29       33  
Foreign exchange gain           800                   800  
Income (loss) before income taxes   $ 865     $ 863     $ (221 )   $ (3,505 )   $ (1,998 )
                                         
Depreciation and amortization included above   $ 413     $ 355     $     $ 18     $ 786  
                                         
Share-based compensation included in above:                                        
Selling, general and administrative     28     $ 21           $ 159       208  
Total   $ 28     $ 21     $     $ 159     $ 208  
                                         
Capital expenditures   $ 576     $ 28     $     $     $ 604  

Three months ended January 31, 2017

  Clinical
Labs
    Life
Sciences
    Therapeutics     Other     Consolidated  
Revenues:                                        
Clinical laboratory services   $ 18,837                       $ 18,837  
Product revenues         $ 6,983                   6,983  
Royalty and license fee income           440                   440  
      18,837       7,423                   26,260  
Operating costs and expenses:                                        
Cost of clinical laboratory services     11,052                         11,052  
Cost of product revenues           3,520                   3,520  
Research and development           516     $ (33 )           483  
Selling, general and administrative     5,897       2,905           $ 2,416       11,218  
Provision for uncollectible accounts receivable     594       85                   679  
Legal fee expense     49       16             305       370  
Total operating costs and expenses     17,592       7,042       (33 )     2,721       27,322  
                                         
Operating income (loss)     1,245       381       33       (2,721 )     (1,062 )
                                         
Other income (expense):                                        
Interest     (28 )     12             95       79  
Other     17                   7       24  
Foreign exchange loss           (94 )                 (94 )
Income (loss) before income taxes   $ 1,234     $ 299     $ 33     $ (2,619 )   $ (1,053 )
                                         
Depreciation and amortization included above   $ 394     $ 501     $     $ 20     $ 915  
                                         
Share-based compensation included in above:                                        
Cost of clinical laboratory services   $ 1                       $ 1  
Selling, general and administrative     23     $ 15           $ 202       240  
Total   $ 24     $ 15     $     $ 202     $ 241  
                                         
Capital expenditures   $ 175     $     $     $     $ 175  

Six months ended January 31, 2018

  Clinical
Labs
    Life
Sciences
    Therapeutics     Other     Consolidated  
Revenues:                                        
Clinical laboratory services   $ 39,864                       $ 39,864  
Product revenues         $ 14,203                   14,203  
Royalty and license fee income           561                   561  
      39,864       14,764                   54,628  
Operating costs and expenses:                                        
Cost of clinical laboratory services     23,772                         23,772  
Cost of product revenues           7,266                   7,266  
Research and development           1,114     $ 445             1,559  
Selling, general and administrative     12,202       5,513           $ 4,246       21,961  
Provision for uncollectible accounts receivable     1,600       (7 )                 1,593  
Legal fee expense     21       28             2,082       2,131  
Total operating costs and expenses     37,595       13,914       445       6,328       58,282  
                                         
Operating income (loss)     2,269       850       (445 )     (6,328 )     (3,654 )
                                         
Other income (expense):                                        
Interest     (48 )     23             367       342  
Other     17       8             44       69  
Foreign exchange gain           605                   605  
Income (loss) before income taxes   $ 2,238     $ 1,486     $ (445 )   $ (5,917 )   $ (2,638 )
                                         
Depreciation and amortization included above   $ 817     $ 681     $     $ 37     $ 1,535  
                                         
Share-based compensation included in above:                                        
Selling, general and administrative     60     $ 44           $ 309       413  
Total   $ 60     $ 44     $     $ 309     $ 413  
                                         
Capital expenditures   $ 994     $ 72     $     $     $ 1,066  

Six months ended January 31, 2017

  Clinical
Labs
    Life
Sciences
    Therapeutics     Other     Consolidated  
Revenues:                                        
Clinical laboratory services   $ 37,395                       $ 37,395  
Product revenues         $ 14,409                   14,409  
Royalty and license fee income           740                   740  
      37,395       15,149                   52,544  
Operating costs and expenses:                                        
Cost of clinical laboratory services     21,948                         21,948  
Cost of product revenues           6,829                   6,829  
Research and development           1,143     $ 162             1,305  
Selling, general and administrative     11,849       5,851           $ 5,012       22,712  
Provision for uncollectible accounts receivable     1,260       88                   1,348  
Legal fee expense     101       28             613       742  
Total operating costs and expenses     35,158       13,939       162       5,625       54,884  
                                         
Operating income (loss)     2,237       1,210       (162 )     (5,625 )     (2,340 )
                                         
Other income (expense):                                        
Interest     (57 )     22             160       125  
Other     119                   24       143  
Foreign exchange loss           (455 )                 (455 )
Income (loss) before income taxes   $ 2,299     $ 777     $ (162 )   $ (5,441 )   $ (2,527 )
                                         
Depreciation and amortization included above   $ 795     $ 1,009     $     $ 38     $ 1,842  
                                         
Share-based compensation included in above:                                        
Cost of clinical laboratory services   $ 3                       $ 3  
Selling, general and administrative     40     $ 26           $ 323       389  
Total   $ 43     $ 26     $     $ 323     $ 392  
                                         
Capital expenditures   $ 587     $ 102     $     $     $ 689